[Use of splenin for the purpose of immunocorrection in patients with seroresistance following syphilis treatment].
Bakhmet'eva
T M
TM
Lonshakov
Iu I
IuI
Petrova
I V
IV
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000917:Antibody Formation / Q000187:drug effects; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D013587:Syphilis / Q000188:drug therapy* / Q000276:immunology; D013588:Syphilis Serodiagnosis; D013592:Syphilis, Latent / Q000188:drug therapy / Q000276:immunology; D013946:Thymopoietins / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D013946:Thymopoietins; D013951:Thymus Hormones; C032841:thymopoietin III
Primenenie splenina s tsel'iu immunokorrektsii u bol'nykh s serorezistentnost'iu posle lecheniia sifilisa.